Adverse Events in the Neonatal Intensive Care Unit: Development, Testing, and Findings of an NICU-Focused Trigger Tool to Identify Harm in North American NICUs

Paul J. Sharek(University of Washington), David C. Classen(Baker Hughes (United States)), Wilbert H. Mason(Children's Hospital of Los Angeles), Hema Bisarya(Child Health Corporation of America), Cary Thurm(Child Health Corporation of America), James E. Gray(Harvard University), Donald A. Goldmann(Boston Children's Hospital), Jeffrey D. Horbar(Cleveland Clinic Lerner College of Medicine), W. H. Edwards, Gautham Suresh(Medical University of South Carolina)
PEDIATRICS
October 1, 2006
10.1542/peds.2006-0565
Cited by 341

Related Papers

The Timing of Prophylactic Administration of Antibiotics and the Risk of Surgical-Wound Infection
|New England Journal of Medicine|1992|1.8k
Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality
|JAMA|1997|1.5k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k
Adverse Drug Events in Hospitalized Patients<subtitle>Excess Length of Stay, Extra Costs, and Attributable Mortality</subtitle>
|JAMA|1997|1.1k
A Computer-Assisted Management Program for Antibiotics and Other Antiinfective Agents
|New England Journal of Medicine|1998|1.1k